These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Pogge von Strandmann E; Simhadri VR; von Tresckow B; Sasse S; Reiners KS; Hansen HP; Rothe A; Böll B; Simhadri VL; Borchmann P; McKinnon PJ; Hallek M; Engert A Immunity; 2007 Dec; 27(6):965-74. PubMed ID: 18055229 [TBL] [Abstract][Full Text] [Related]
3. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles. Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836 [TBL] [Abstract][Full Text] [Related]
4. Important role for NKp30 in synapse formation and activation of NK cells. Wang H; Zheng X; Wei H; Tian Z; Sun R Immunol Invest; 2012; 41(4):367-81. PubMed ID: 22221078 [TBL] [Abstract][Full Text] [Related]
5. Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30. Balsamo M; Zambello R; Teramo A; Pedrazzi M; Sparatore B; Scordamaglia F; Pende D; Mingari MC; Moretta L; Moretta A; Semenzato G; Vitale M Exp Hematol; 2009 Oct; 37(10):1167-75. PubMed ID: 19580844 [TBL] [Abstract][Full Text] [Related]
6. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
7. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells]. Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338 [TBL] [Abstract][Full Text] [Related]
8. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Vitale M; Della Chiesa M; Carlomagno S; Pende D; Aricò M; Moretta L; Moretta A Blood; 2005 Jul; 106(2):566-71. PubMed ID: 15784725 [TBL] [Abstract][Full Text] [Related]
9. A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells. Binici J; Hartmann J; Herrmann J; Schreiber C; Beyer S; Güler G; Vogel V; Tumulka F; Abele R; Mäntele W; Koch J J Biol Chem; 2013 Nov; 288(48):34295-303. PubMed ID: 24133212 [TBL] [Abstract][Full Text] [Related]
10. NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Fuller CL; Ruthel G; Warfield KL; Swenson DL; Bosio CM; Aman MJ; Bavari S Cell Microbiol; 2007 Apr; 9(4):962-76. PubMed ID: 17381429 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity. Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190 [TBL] [Abstract][Full Text] [Related]
12. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity. Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150 [TBL] [Abstract][Full Text] [Related]
13. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). De Maria A; Fogli M; Costa P; Murdaca G; Puppo F; Mavilio D; Moretta A; Moretta L Eur J Immunol; 2003 Sep; 33(9):2410-8. PubMed ID: 12938217 [TBL] [Abstract][Full Text] [Related]
14. Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan. Warren HS; Jones AL; Freeman C; Bettadapura J; Parish CR J Immunol; 2005 Jul; 175(1):207-12. PubMed ID: 15972650 [TBL] [Abstract][Full Text] [Related]
15. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. Tjwa ET; van Oord GW; Hegmans JP; Janssen HL; Woltman AM J Hepatol; 2011 Feb; 54(2):209-18. PubMed ID: 21095036 [TBL] [Abstract][Full Text] [Related]
16. The bidirectional crosstalk between human dendritic cells and natural killer cells. Wehner R; Dietze K; Bachmann M; Schmitz M J Innate Immun; 2011; 3(3):258-63. PubMed ID: 21411969 [TBL] [Abstract][Full Text] [Related]
17. Shaping of adaptive immunity by innate interactions. Castriconi R; Della Chiesa M; Moretta A C R Biol; 2004 Jun; 327(6):533-7. PubMed ID: 15330252 [TBL] [Abstract][Full Text] [Related]
18. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. Tallerico R; Todaro M; Di Franco S; Maccalli C; Garofalo C; Sottile R; Palmieri C; Tirinato L; Pangigadde PN; La Rocca R; Mandelboim O; Stassi G; Di Fabrizio E; Parmiani G; Moretta A; Dieli F; Kärre K; Carbone E J Immunol; 2013 Mar; 190(5):2381-90. PubMed ID: 23345327 [TBL] [Abstract][Full Text] [Related]
19. Human natural killer lymphocytes through the engagement of natural cytotoxicity receptors and NKG2D can trigger self-aggression. Poggi A; Zocchi MR Autoimmun Rev; 2007 Apr; 6(5):295-9. PubMed ID: 17412301 [TBL] [Abstract][Full Text] [Related]
20. Preparation and functional identification of a monoclonal antibody against the recombinant soluble human NKp30 receptor. Wang H; Zheng X; Wei H; Tian Z; Sun R Int Immunopharmacol; 2011 Nov; 11(11):1732-9. PubMed ID: 21718806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]